Skip to nav Skip to content

Reimbursement and Compensation Policy

Fair and adequate reimbursement for infectious diseases physicians is a key IDSA policy priority. In the public policy arena, the Society promotes the value of ID physicians and supports access to and appropriate reimbursement for infectious diseases services. IDSA also supports funding and policies that foster ID training. The Society also advocates for access to appropriate treatments for patients with serious infections. IDSA’s positions on specific reimbursement and compensation issues that impact the practice of infectious diseases and advocacy alerts to key policy priorities are provided below. 

 

 

 

Key policy priorities

  • In mid July of 2025, CMS released the CY 2026 Medicare Physician Fee Schedule Proposed Rule. IDSA has drafted a response in opposition to the Practice Expensive proposals which will result in a 9% cut to all facility-based ID physicians. In the letter, IDSA urges CMS to work with ID physicians to better capture specialty impact data when drafting any future proposals. 

  • In July 2025, CMS released the CY 2026 Hospital Outpatient Prospective Payment System (OPPS) proposed rule. IDSA's comment letter addresses key issues including site-neutral payment for drug administration, vaccine access, 340B payment adjustments, and the importance of maintaining strong infection prevention measures for healthcare workers.

  • IDSA President Steven Schmitt, MD, FIDSA, submitted a letter to the Senate Finance Committee leadership in response to their white paper on Medicare physician payment. In the letter, IDSA urged Congress to include ID physician incentives in upcoming payment model changes.

Advertisement

Policy News

Loading...

2024-2025

 

 

2025

2024

Related websites

Medicare Evidence Development & Coverage Advisory Committee

Medicare Payment Advisory Commission

Get involved

Join us in our advocacy efforts to make a difference in the fight against infectious diseases. Join the MAP and check out our current advocacy opportunities on the Take Action tab.